-
VectorBuilder Partners with Minaris Regenerative Medicine to Enhance Gene Therapy Solutions
•
VectorBuilder, a specialist in genetic engineering based in China, has entered into a strategic partnership with Minaris Regenerative Medicine, a cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Japan-headquartered Showa Denko Materials Co., Ltd. This collaboration aims to integrate VectorBuilder’s superior R&D and…
-
VectorBuilder Partners with Sino Biological to Boost Global Biological Reagents Market
•
VectorBuilder, a genetic engineering specialist based in Guangzhou and nurtured by the state-owned Guangzhou Industrial Investment and Capital Operation Holding Group, has entered into a partnership with Sino Biological, Inc. (SHE: 301047), a global leader in the provision of mammalian cell-based recombinant proteins, antibodies, and related contract research services. This…
